Number of patent litigations.

No definition available.

Name:	ntra_LossContingencyPatentsLitigationsNumber
Namespace Prefix:	ntra_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow for clinical samples and data for oncology development.

+ References

No definition available.

+ Details

Name:	ntra_PaymentsForClinicalSamplesAndDataForOncologyDevelopment
Namespace Prefix:	ntra_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The number of employees included in pending claim.

+ References

No definition available.

+ Details

Name:	ntra_PendingClaimNumberOfEmployees
Namespace Prefix:	ntra_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims.

+ References

No definition available.

+ Details

Name:	ntra_PendingClaimsNumber
Namespace Prefix:	ntra_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of potential milestones payable to other party.

+ References

No definition available.

+ Details

Name:	ntra_PotentialMilestonePaymentsToOtherParty
Namespace Prefix:	ntra_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of entity's patents that another entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483049/450-30-50-1

+ Details

Name:	us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_LitigationReserve
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount awarded from other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 440
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482648/440-10-50-6

+ Details

Name:	us-gaap_RecordedUnconditionalPurchaseObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_ClinicalSamplesAndDataForOncologyDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_CaredxSPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_ArcherdxPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_RavgenPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_GenosityInc.PatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_InivataPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_InivitaPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_NeoGenomicsPatentCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_GuardantIncCaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=ntra_ClassActionLawsuitMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details) $ in Thousands	1 Months Ended														3 Months Ended	12 Months Ended
Commitments and Contingencies (Details) $ in Thousands	Feb. 27, 2025 employee	Nov. 30, 2024 USD ($)	Jan. 31, 2024 USD ($)	Jul. 31, 2023 patent	Jun. 30, 2023 USD ($) patent	Dec. 31, 2022 lawsuit	Mar. 31, 2022 USD ($)	Nov. 30, 2021 patent	Sep. 30, 2021 patent	May 31, 2021 lawsuit	Jan. 31, 2021 patent	Oct. 31, 2020 patent	Jun. 30, 2020 patent	Mar. 31, 2020 lawsuit patent	Mar. 31, 2024 USD ($) patent	Dec. 31, 2024 USD ($)	Feb. 28, 2022 lawsuit
Other commitments
Accrued settlement liability																$ 12,600
Contractual commitments																171,262
Clinical samples and data for oncology development
Other commitments
Contractual commitments																13,000
Acquired clinical samples and data for oncology development																7,000
Potential payments to third party vendor																$ 50,000
CareDX Patent Case
Other commitments
Number of patent litigations \| lawsuit														2
Loss contingency, patents allegedly infringed, number \| patent									3					3
Gain contingency, patents allegedly infringed, number \| patent															1
Amount awarded to other party							$ 44,900
Amount awarded from other party															$ 96,300
ArcherDX Case
Other commitments
Gain contingency, patents allegedly infringed, number \| patent					3						3
Amount awarded from other party					$ 19,350
Ravgen Patent Case
Other commitments
Loss contingency, patents allegedly infringed, number \| patent													2
Amount awarded to other party			$ 57,000
Genosity Inc. Patent Case
Other commitments
Gain contingency, patents allegedly infringed, number \| patent												1
Inivata Patent Case
Other commitments
Number of patent litigations \| lawsuit						2
Inivitae Patent Case
Other commitments
Loss contingency, patents allegedly infringed, number \| patent								3
NeoGenomics Patent Case
Other commitments
Gain contingency, patents allegedly infringed, number \| patent				2
Guardant Case
Other commitments
Number of lawsuits \| lawsuit										2
Amount awarded to other party		$ 292,500
Guardant Case \| Subsequent event
Other commitments
Pending claim, number of employees \| employee	2
Class action
Other commitments
Number of lawsuits \| lawsuit																	2